Slocum, Gordon & Co’s Viatris VTRS Stock Holding History

Slocum, Gordon & Co’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12	Closed	-$133	–	148
2022 Q4	$133	Buy	+12	New	+$125	﹤0.01%	138

Other funds holding VTRS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Slocum, Gordon & Co's VTRS Position: Q1 2023 in Review

Slocum, Gordon & Co sold out of Viatris (VTRS) in Q1 2023, closing a stake of 12 shares — an estimated $133 sold.

Slocum, Gordon & Co first reported a position in VTRS in Q4 2022 and held it in 1 quarter. The position peaked at $133 in Q4 2022. 988 funds tracked by Wall St. Rank hold VTRS as of Q1 2023.

Slocum, Gordon & Co reported no remaining Viatris position as of Q1 2023 after selling out during the quarter.
Slocum, Gordon & Co sold 12 Viatris shares in Q1 2023, an estimated $133.
Slocum, Gordon & Co first reported a position in Viatris in Q4 2022 and held it in 1 quarter.
Slocum, Gordon & Co's Viatris position peaked at $133 in Q4 2022.
988 funds tracked by Wall St. Rank held Viatris as of Q1 2023.

Based on Slocum, Gordon & Co's 13F filing for Q1 2023, filed 14 Dec 2023.